{
  "ticker": "LLY",
  "target_date": "2025-12-02",
  "actual_date": "2025-12-02",
  "collected_at": "2025-12-08T12:36:25.780567",
  "price": {
    "open": 1052.57,
    "high": 1068.18,
    "low": 1040.36,
    "close": 1046.1199951171875,
    "volume": 3280000,
    "change_1d_pct": -1.11,
    "change_7d_pct": 0.27,
    "change_30d_pct": 29.51
  },
  "technicals": {
    "rsi_14": 64.28,
    "sma_20": 1018.63,
    "sma_50": 893.49,
    "macd": 55.482,
    "macd_signal": 58.979,
    "macd_histogram": -3.497,
    "bb_upper": 1138.97,
    "bb_lower": 898.3,
    "price_vs_sma20_pct": 2.7,
    "price_vs_sma50_pct": 17.08,
    "volume_ratio": 0.75
  },
  "fundamentals": {
    "market_cap": 891109376000,
    "pe_ratio": 48.70333,
    "forward_pe": 43.867386,
    "price_to_book": 37.426018,
    "price_to_sales": 14.996842,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.61,
    "pct_from_52w_low": 59.36
  },
  "macro": {
    "spy": {
      "price": 681.53,
      "change_1d_pct": 0.19,
      "change_7d_pct": 3.41
    },
    "vix": {
      "level": 16.59,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.09
    },
    "dollar_index": {
      "level": 99.36
    },
    "gold": {
      "price": 4186.6
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "ReAlta Life Sciences Designates Dr. Howard Berman as Executive Chairman",
      "source": "Yahoo",
      "datetime": 1764712000,
      "summary": "By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive Chairman of its Board of Directors, effective immediately. \u201cHis proven track record in advancing innovative immunology-based therapies and creating value, positions ReAlta for disciplined growth",
      "url": "https://finnhub.io/api/news?id=a7d6db65b12ed28cd92cc814b31efd5f3c596ea5fe8ad7c6ce46fc1e586e8840"
    },
    {
      "headline": "LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website",
      "source": "Yahoo",
      "datetime": 1764696480,
      "summary": "Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.",
      "url": "https://finnhub.io/api/news?id=8cd09b616f02a25ba2b8041e7a763f4cbea13fb60019a4e9f84a5719f2dff642"
    },
    {
      "headline": "Eli Lilly & Co. stock underperforms Tuesday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1764693060,
      "summary": "Eli Lilly & Co. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=7616037c642f27023d395c65583e83c58ef1d5bac612dcad392c8d7c1df9261a"
    },
    {
      "headline": "Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple",
      "source": "Yahoo",
      "datetime": 1764693055,
      "summary": "After a rough pullback, the major indices are attempting to rebound higher. Helping, not only is Bitcoin starting to rebound, but so are down but not out tech stocks. Plus, markets are optimistic that the Federal Reserve will cut interest rates again next week. We also continue to see a significant ",
      "url": "https://finnhub.io/api/news?id=4f7d7446b08ed8c1b85299d8c6823fc0ab093d91e3c77deecc9a108b8f87bfcc"
    },
    {
      "headline": "Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript",
      "source": "SeekingAlpha",
      "datetime": 1764683007,
      "summary": "Eli Lilly and Company (LLY) Citi Annual Global Healthcare Conference 2025 December 2, 2025 10:30 AM ESTCompany ParticipantsIlya Yuffa - Executive VP and...",
      "url": "https://finnhub.io/api/news?id=e46434fe3f5e18b96f857f5c7f268d44616f1643097c4f4b816ffb3fa9012883"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041104.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000093/xslF345X05/form4-11262025_041104.xml"
    },
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000092/xslF345X05/form4-11262025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-25",
      "description": "xslF345X05/form4-11252025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/xslF345X05/form4-11252025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-24",
      "description": "xslF345X05/form4-11242025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/xslF345X05/form4-11242025_041101.xml"
    },
    {
      "form": "8-K",
      "date": "2025-11-21",
      "description": "lly-20251118.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}